Barry Robinson, a bowel cancer patient who is appealing to h

UNITED KINGDOM - MAY 12: Barry Robinson, a bowel cancer patient who is appealing to his local health authority for Erbitux, a drug not recommend by The National Institute for Health and Clinical Excellence, NICE, poses in London, U.K., on Saturday May 12, 2007. After Robinson's bowel cancer spread to his lungs in January, doctors told the U.K. resident his life might be extended with ImClone Systems Inc.'s Erbitux. Britain's National Health Service has refused to pay for the treatment, leaving the 60-year-old retired soldier to raise 20,000 pounds ($39,500) to purchase the drug. (Photo by Daniel Hambury/Bloomberg via Getty Images)